09Oct
Caremark Round II: Beware Red Flags in Drug Development
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By:
Goodwin
Related
From independent contractors to privacy to arbitration agreements - the California Legislature was b...
Read More >
The California Court of Appeal recently discussed an owner's remedies (and some limits to those reme...
Read More >
Arizona employers often ask me what kind of flexibility they have in adopting paid time off (“PTO”...
Read More >
A company that does not perform adequate due diligence prior to a merger or acquisition may face bot...
Read More >
A lot has happened since the Fair Work Commission (FWC) commenced its review of modern awards in 201...
Read More >
For an entity that has historically placed an emphasis on maintaining the secrecy of its proceedings...
Read More >